Pharmaceutical Combination Comprising an Antifungal Agent and an Active Substance Selected From Carveol, Eugenol, Thymol, Borneol, Carvacrol, and Alpha- and Beta-Ionones

A pharmaceutical composition comprising:

• at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone, and isomers, derivatives, or mixtures thereof;
• and
• at least one second therapeutically active substance which is an antifungal agent selected from the group consisting of pyrimidines, azoles, echinocandins and mixtures thereof.

A kit comprising:

• at least one first container containing a first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone and isomers, derivatives or mixtures thereof, and
• at least one second container containing a second therapeutically active substance which is an antifungal agent selected from the group consisting of pyrimidines, azoles, echinocandins and mixtures thereof.

A method for treating an infection caused by a fungus comprising the simultaneous or sequential administration to a patient having a fungal infection of:

• at least one first therapeutically active substance selected from the group consisting of carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, beta-ionone and isomers, derivatives, or mixtures thereof, and
• at least one second therapeutically active substance which is an antifungal agent, selected from the group consisting of pyrimidines, azoles, echinocandins, and mixtures thereof.